<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966459</url>
  </required_header>
  <id_info>
    <org_study_id>PML_DOC_0803</org_study_id>
    <nct_id>NCT00966459</nct_id>
  </id_info>
  <brief_title>Computed Tomography (CT) and Lung Function Data Collection for Computational Fluid Dynamics (CFD) in Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
  <official_title>Computed Tomography (CT) and Lung Function Data Collection for Computational Fluid Dynamics (CFD) in COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, 20 COPD patients will undergo a high-resolution/multi slice CT scan and lung&#xD;
      function tests to obtain patient specific geometries of the central and peripheral small&#xD;
      airways and patient specific boundary conditions.&#xD;
&#xD;
      With Computational Fluid Dynamics (CFD), the investigators will be able to reconstruct the&#xD;
      geometry and measure the resistance of the peripheral airways.&#xD;
&#xD;
      In a later stage, CFD will be used to simulate the reaction of the airways on various&#xD;
      inhalation medications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To obtain patient specific geometries of the central and peripheral small airways</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>To obtain patient specific boundary conditions</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>To measure the resistance of the peripheral airways</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To measure the reaction of the airways on various inhalation medications</measure>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Computed Tomography</intervention_name>
    <description>1 low-dose CT is taken</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with documented COPD based on the following criteria:&#xD;
&#xD;
               -  Smoking history of at least 10 pack-years.&#xD;
&#xD;
               -  Decreased Tiffeneau index (FEV1/(F)VC &lt; 0.70).&#xD;
&#xD;
          2. Patients aged ≥ 40 years.&#xD;
&#xD;
          3. Patients should present moderate to very severe COPD with an FEV1 &lt; 80% of predicted&#xD;
             (GOLD 2, 3 and 4).&#xD;
&#xD;
          4. Patients should be treated according to GOLD guidelines.&#xD;
&#xD;
          5. Maintained on stable respiratory medications for 4 weeks prior to visit 1&#xD;
&#xD;
          6. Able to perform lung function tests.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients below the age of 40.&#xD;
&#xD;
          2. Patients who are pregnant or are breast-feeding.&#xD;
&#xD;
          3. A respiratory infection or exacerbation of COPD in the four weeks prior to screening.&#xD;
&#xD;
          4. BMI &gt; 35 kg/m².&#xD;
&#xD;
          5. Patients treated with BiPAP or CPAP.&#xD;
&#xD;
          6. Known active tuberculosis.&#xD;
&#xD;
          7. A history of asthma, cystic fibrosis, central bronchiectasis, interstitial lung&#xD;
             disease or pulmonary thromboembolic disease.&#xD;
&#xD;
          8. A history of thoracotomy with pulmonary resection.&#xD;
&#xD;
          9. Active or untreated malignancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Antwerp</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <study_first_submitted>August 26, 2009</study_first_submitted>
  <study_first_submitted_qc>August 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2009</study_first_posted>
  <last_update_submitted>August 31, 2009</last_update_submitted>
  <last_update_submitted_qc>August 31, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof Dr Wilfried De Backer</name_title>
    <organization>University Hospital Antwerp, Department of Respiratory Medicine</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

